Biosynthesis of a VLP-type nanocarrier specific to cancer cells using the BEVS expression system for targeted drug delivery

OBJECTIVE: Canine parvovirus (CPV) is a small virus without an envelope that consists of three viral proteins including VP1, VP2, and VP3. Exclusively, the VP2 can form a typically CPV-sized virus-like particle (CPV-VLP) that can be used as a biological nanocarrier for diagnostic and therapeutic pur...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashemzadeh, Mohammad Sadegh, Gharari, Nariman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932404/
https://www.ncbi.nlm.nih.gov/pubmed/36795253
http://dx.doi.org/10.1186/s43141-023-00479-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932404/
https://www.ncbi.nlm.nih.gov/pubmed/36795253
http://dx.doi.org/10.1186/s43141-023-00479-9

Ejemplares similares